A previous study has implicated that downregulation of PRKDC-sensitized MCF-7 cells to chemodrugs in vitro, which is a potential prognostic and predictive marker of response to adjuvant chemotherapy in breast cancer patients [63]. The gene discussed is PRKDC; the disease is breast cancer.